Dr. Vinay Prasad is resuming leadership of the FDA center that regulates vaccines and biotech therapies, a spokesperson for ...

Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...

The U.S. Food and Drug Administration (FDA)'s top vaccine regulator is returning to his post less than two weeks after the ...

WASHINGTON, DC – Massachusetts based Indian American Arvinder “Arvi” Singh Bahal has always had his eyes on the horizon – the real estate investor has built a life defined by adventure ...

Vinay Prasad, the controversial head of the Food and Drug Administration office that oversees vaccines and gene therapy, has abruptly left the agency after less than three months on the job.

Vinay Prasad, controversial FDA official, abruptly departs agency Prasad’s exit ends a tumultuous tenure during which he led a reworking of agency guidelines on COVID vaccines and his office got ...

American companies are racing to develop gene therapies that treat dreadful maladies, with often spectacular results. But progress isn’t inevitable, and the story of a drug for a rare condition ...

Also in the interview, Makary defended Dr. Vinay Prasad, a senior FDA official who oversees vaccine regulations in the United States.

Since Dr. Vinay Prasad’s appointment as a key political voice within FDA, the tone of U.S. biotech policy has shifted from enabling innovation to second-guessing it. Alongside figures ...

After years of bashing the medical establishment, Drs. Vinay Prasad and Marty Makary are stuck in a trap. Any attempt to escape only tightens its grip.

CBER Director Vinay Prasad had previously spoken out against his predecessor Peter Marks, who in June 2024 overruled reviewers and granted full approval to the therapy despite it having failed its ...